In re: Wellbutrin XL Antitrust Litigation, No. 08-cv-2431 (E.D. Pa.)

In the Wellbutrin XL case, Faruqi & Faruqi, LLP represents a certified class of direct purchasers of GlaxoSmithKline’s branded antidepressant tablet Wellbutrin XL (extended-release bupropion hydrochloride).  The suit alleges that GSK and its co-conspirator, Biovail (now known as Valeant), engaged in an overarching anticompetitive scheme in order to delay less-expensive competition from generic versions of Wellbutrin XL.  The scheme included 4 sham patent infringement lawsuits, a baseless FDA petition, and later an  illegal “non-compete” agreement with the first-filed generic competitor to delay launching one of the 2 dosage strengths of  generic Wellbutrin XL for an additional 18 months in exchange for GSK and Biovail’s withholding an authorized generic version of Wellbutrin XL.  The suit alleges that, as a result of the scheme, direct purchasers were overcharged almost $2.5 billion on their purchases of extended-release bupropion hydrochloride, in violation of §§ 1 and 2 of the Sherman Act. The case partially settled for $37.5 million in 2012 and is proceeding against the non-settling defendant, GSK.

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.


Filed on 07/10/2008


1617 JFK Boulevard, Suite 1550

19103 Philadelphia, Pennsylvania

Phone (215) 277-5770

Fax (215) 277-5771


Peter Kohn Phone (215) 277-5770 Fax (215) 277-5771

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885


3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania